期刊文献+

5-硝基咪唑类药物治疗细菌性阴道病的临床疗效比较 被引量:5

Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis
原文传递
导出
摘要 目的评价5-硝基咪唑类药物口服和联合用药治疗细菌性阴道病的疗效和副作用,从而为病人提供经济有效的治疗方法。方法开放的随机前瞻性的研究,将278例有细菌性阴道病的病人分成8组:(1)口服甲硝唑缓释片,每次750mg,每天1次,连续使用7d。(2)口服甲硝唑缓释片,每次750mg,每天1次,连续使用7d,同时阴道用替硝唑栓,每天250mg,连续使用7d。(3)口服替硝唑,每次1g,首次加倍,每日1次,连服3d。并使用阴道用替硝唑栓,每天250mg,连续使用7d。(4)口服替硝唑,每次1g,首次加倍,每日1次,连服3d。(5)口服奥硝唑3d,每天2次,每次500mg并使用阴道用替硝唑栓,每天250mg,连续使用7d。(6)口服奥硝唑3d,每天2次,每次500mg。(7)以单一剂量口服塞克硝唑2g并使用阴道用替硝唑栓,每天250mg,连续使用7d。(8)一次性口服塞克硝唑2g。结果药物联合使用病人的临床治愈率范围为80.00%~86.11%,仅仅口服用药病人的临床治愈率范围56.76%~62.50%。几种5-硝基咪唑类药物口服和阴道联合用药的疗效与仅仅口服用药疗效差异有统计学意义,口服用药组之间和联合用药组之间疗效差异都无统计学意义。结论甲硝唑、替硝唑、奥硝唑、塞克硝唑口服合并替硝唑阴道用药疗效比单独口服好。甲硝唑、替硝唑、奥硝唑、塞克硝唑之间疗效差异无统计学意义,从耐药性及长期用药的安全性和依从性来看,奥硝唑和塞克硝唑具有优势。 Objective To evaluate the efficacy and adverse effects of 5-nitroimidazole derivatives in treatment of bacterial vaginosis (BV). Methods 278 BV patients were randomly divided into 8 groups to be treated with (1) oral metronidazole sustained release tablet 750 mg/day for 7 days, (2) oral metronidazole sustained release tablet 750 mg/day for 7 days and vaginal tinidazlole 250 mg for 7 days, (3) oral tinidazlole 1 g/day for 3 days (2 g for the first dose), (4) oral tinidazlole 1 g/day for 3 days (2 g for the first dose), (5) oral ornidazole 2 ×500 mg/day for3 days and vaginal tinidazlole 250 mg for7 days, (6) oral ornidazole 2× 500 mg/day for 3 days, ( 7 ) oral secnidazole 2 g in a single dose and vaginal tinidazlole 250 mg for 7 days, and (8) oral secnidazole 2 g in a single dose. Results The clinical cure rates of the oral administration groups were 56. 76% - 62. 50%, all significantly lower than those of the oral/vaginal combination groups ( 80. 00% - 86. 11% , all P 〈 0. 05 ). There was nit significantly difference in efficacy level among the only oral treatment groups and the oral/vaginal combination groups (all P 〉0. 05 ). Conclusion Combination of oral and vaginal administration of 5-nitroimidazole derivatives is more effective in treatment of BV than oral administration only.
出处 《中华医学杂志》 CAS CSCD 北大核心 2008年第31期2201-2203,共3页 National Medical Journal of China
关键词 细菌性阴道病 替硝唑 甲硝唑 奥硝唑 塞克硝唑 Bacterial vaginosis Metronidazole Tinidazole Ornidazole Secnidazole
  • 相关文献

参考文献12

  • 1Gonzalez Pedraza Aviles A, Ortiz Zaragoza MC, Irigoyen Coria A. Bacterial vaginosis a "broad overview". Rev Latinoam Microbiol, 1999, 41:25-34.
  • 2Hillier SL, Holmes KK. Bacterial Vaginosis. Sexually transmitted disease, 1999,563-557.
  • 3French JI, McGregor JA, Draper D, et al. Gestational bleeding, bacterial vaginosis, and common reproductive tract infections: risk for preterm birth and benefit of treatment. Obstet Gynecol, 1999, 93:715-724.
  • 4Hemsell DL, Nobles B, Heard MC. Recognition and treatment of posthysterectomy pelvic infections. Infec Surg, 1998, 1:47-68.
  • 5夏美霞,陈小青,严杰.5-硝基咪唑类药物体外抗无芽孢厌氧菌效果的观察[J].微生物学杂志,2001,21(4):58-59. 被引量:1
  • 6Saracoglu F,Gol K,shin I, et al. Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole, secnidazole and metronidazole. Int J Obstet Gynecol, 1995, 62: 59-61.
  • 7Milani M, Barcellona E, Agnello A. Efficacy of the combination of 2g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis; a randomized, investigator-blinded controlled trial. Eur J Obstet Gynecol Reprod Biol, 2003, 109:67-71.
  • 8Baylson FA, Nyirjesy P, Weitz MV. Treatment of recurrent bacterial vaginosis with tindazole. Obstet Gynecol, 2004, 104: 931-932.
  • 9Baloglu E, Ozyazici M, Baloglu A, et al. A randomized controlled trial of a new ovule formulation of omidazole for the treatment of bacterial vaginosis. J Clin Pharm Ther, 2003, 28: 131-136.
  • 10Mohanty KC, Deighton R. Comparison of 2 g single dose of metronidazole, nimorazole and tinidazole in the treatment of vaginitis associated with Gardnerella vaginalis. J Antimicrob Chemother, 1987, 19:393-399.

二级参考文献16

  • 1王少华,赵艳,刘振胜,李志平,王霞,赵美玲,齐方梅.塞克硝唑阴道泡腾片人体药代动力学研究[J].中国临床药理学与治疗学,2006,11(1):66-69. 被引量:2
  • 2陈莉丽 章锦才 等.口腔厌氧菌和牙周病[M].北京:人民卫生出版社,1998.139-154,196-209.
  • 3Cimerman B,Camilo Coura LC,Salle JM,et al.Evaluation of secnidazole gel and tinidazole suspension in the treatment of giardiasis in children[J].Braz J Infect Dis,1997,1(5):241-245.
  • 4Di Prisco MC,Jimenez JC,Rodriguez N,et al.Clinical trial with secnidazole in a single dose in Venezuelan children infected by Giardia intestinalis[J].Invest Clin,2000,41(3):179-183.
  • 5Lamp KC,Freeman CD,Klutman NE,et al.Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials[J].Clin Pharmacokinet,1999,36(5):353-373.
  • 6Botero D.An overview of the clinical experience of secnidazole in giardiasis and amebiasis[J].Drug Invest,1994,8(Suppl 1):S47-S52.
  • 7Tenenbaum H,Cuisinier FJG,Le Liboux A,et al.Secnidazole concentrations in plasma and crevicular fluid after a single oral dose[J].J Clin Periodontol,1993,20:505-508.
  • 8Sobel JD.Management of vaginosis[J].Drug Invest,1994,8(Suppl 1):26-34.
  • 9Sawyer PR,Brogden RN,Pinder RM,et al.Tinidazole:a review of its antiprotozoal activity and therapeutic efficacy[J].Drugs,1976,11(6):423-440.
  • 10Bagnoli VR.An overview of the clinical experience with secnidazole in bacterial vaginosis and trichomoniasis[J].Drug Invest,1994,8(Suppl 1):S53-S60.

共引文献7

同被引文献66

  • 1沈晓兰,谢涛,刘晓兰,贺志鹏.四种外用抗感染药物治疗细菌性阴道病的多中心、随机、平行、开放性临床研究[J].实用妇科内分泌电子杂志,2020,7(11):44-45. 被引量:2
  • 2石洪珍,高树荣.替硝唑治疗细菌性阴道病86例疗效观察[J].现代医药卫生,2005,21(14):1853-1853. 被引量:1
  • 3Livengood CH. Bacterial vaginosis: an overview for 2009 [ J ] . Rev Obstet Gynecol, 2009, 2:28-37.
  • 4Hay P. How important are the newly described bacteria in bacterial vaginosis? [ J ] . Sex Transm Infect, 2009, 85: 240-241.
  • 5Atashili J, Poole C, Ndumbe PM, et al. Bacterial vaginosis and HIV acquisition: a meta -analysis of published studies [J] . AIDS, 2008, 22:1493 - 1501.
  • 6Denney JM, Culhane JF. Bacterial vaginosis : a problematic infection from both a perinatal and neonatal perspective [ J ] . Semin Fetal Neonatal Med, 2009, 14:200 -203.
  • 7Thomas KK, Sanchez S, Garcia PJ, et al. Why do different criteria for 'cure' yield different conclusions in comparing two treatments for bacterial vaginosis? [ J] . Sex Transm Dis, 2005, 32:526 -530.
  • 8U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Bacterial vaginosis: developing antimicrobial drugs for treatment. 1998 [ EB/OL]. http: //www. fda. gov/downloads/Drugs/ Guidances/ucm070969. odf.
  • 9CDC. Sexually transmitted diseases treatment guidelines 2006 [ J ] . MMWR, 2006, 55 : 1 - 94.
  • 10Cinical Effectiveness Group, British association for sexual health and HIV ( BASHH ). National guideline for the management of bacterial vaginosis 2006 [ EB/OL] . http: // www. bashh, org/documents/62/62, pdf.

引证文献5

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部